Lyra Therapeutics Inc (LYRA) Live Share Price, Invest From India

Lyra Therapeutics Inc Stock Performance

as on April 3, 2026 at 5:37 am IST

Day's Low
Day's High
$0.44
Day's Price Range
$0.51
$0.49
10.20%
Downside
4.08%
Upside
52 Week's Low
52 Week's High
$0.31
52-Week Price Range
$37.50
$0.49
36.73%
Downside
7553.06%
Upside

Lyra Therapeutics Inc share price movements today

Previous Close: $0.44
Open: $0.46
Volume: 583.7K
Day's Low - High: $0.44 - $0.51
52 Week Low - High: $0.31 - $37.50

Lyra Therapeutics Inc Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Lyra Therapeutics Inc Stock Fundamentals & Key Indicators

Check Lyra Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

0.00%

Lyra Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Lyra Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Lyra Therapeutics Inc	BUY	$-	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$43.6B	124.84%	141.09	8.45%
Vertex Pharmaceuticals Incorporated	BUY	$113.6B	105.93%	29.16	32.94%
Beone Medicines Ltd	NA	$35.4B	NA	124.87	5.37%
Regeneron Pharmaceuticals, Inc.	BUY	$82.2B	60.41%	18.72	31.41%

Analyst Recommendation on Lyra Therapeutics Inc Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Lyra Therapeutics Inc. Average target price of $16

Lyra Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Lyra Therapeutics Inc.

What analysts predicted

96.94%UPSIDE

Target Price

$16

Current Price

$0.49

Analyzed by

12 Analysts

Target

$16.00

Lyra Therapeutics Inc target price $16, a slight upside of 96.94% compared to current price of $0.49. According to 12 analysts rating.

Lyra Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	0	0	0	0	0	0	0	0	0	0
Gross Profit	-10	-11	0	0	0	0	0	0	0	0
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-15	-15	-15	-22	-48	-11	-10	-8	-7	-5
Net Profit Margin	-3410.04%	-2877.02%	-10380.82%	-4220.30%	-8048.66%	-6088.72%	-5253.11%	-4670.49%	-4063.93%	-23936.00%

Lyra Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	1	-	-	0	1	1	1
Gross Profit	1	0	-12	0	1	1	1
Operating Income	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-
Net Income	-6	-16	-22	-42	-55	-62	-93
Net Profit Margin	-484.65%	0.00%	0.00%	-14880.70%	-4055.61%	-4023.11%	-6090.94%

Global Institutional Holdings in Lyra Therapeutics Inc

Funds	Holdings
Advisor Group Holdings, Inc.	0%
Sabby Management LLC	7.19%
SBI Securities Co Ltd	0%
Bryn Mawr Trust Company	0%
Valley National Advisers Inc	0.03%

See all

Insights on Lyra Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 6 quarters, -48.13M → -5.98M (in $), with an average increase of 76.2% per quarter
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 67.9% return, outperforming this stock by 167.4%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 24.2% return, outperforming this stock by 118.9%
NEGATIVE IMPACT
Price Dip
In the last 7 days, LYRA stock has moved down by -66.7%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 4 quarters, 209.0K → 25.0K (in $), with an average decrease of 32.9% per quarter

About Lyra Therapeutics Inc

Lyra Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on the development and commercialization of therapies for the localized treatment of patients with chronic rhinosinusitis (CRS). The Company is developing therapies for CRS, a prevalent inflammatory disease of the paranasal sinuses that leads to debilitating symptoms and significant morbidities. LYR-210, the Company’s lead product, is a bioabsorbable nasal implant designed to be administered in a simple, in-office procedure and is intended to deliver six months of continuous anti-inflammatory drug therapy to the sinonasal passages for the treatment of CRS with a single administration. LYR-210, being evaluated in the ENLIGHTEN Phase III clinical program, is intended for patients with and without nasal polyps. The drug embedded within LYR-210 is mometasone furoate (MF).

Organisation	Lyra Therapeutics Inc
E-voting on shares	Click here to vote

FAQs

What is Lyra Therapeutics Inc share price today?

Lyra Therapeutics Inc share price today is $0.49 as on April 3, 2026 at 12:07 am IST at the close of the market. Lyra Therapeutics Inc share today touched a day high of $0.51 and a low of $0.44.

What is the 52 week high and 52 week low for Lyra Therapeutics Inc share?

Lyra Therapeutics Inc share touched a 52 week high of $37.5 on June 2, 2025 and a 52 week low of $0.31 on March 17, 2026. Lyra Therapeutics Inc stock price today i.e. April 3, 2026 at 12:07 am IST is closed at $0.49,which is 98.69% down from its 52 week high and 58.06% up from its 52 week low.

How to invest in Lyra Therapeutics Inc Stock (LYRA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Lyra Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Lyra Therapeutics Inc Shares that will get you 3.0612 shares as per Lyra Therapeutics Inc share price of $0.49 per share as on April 3, 2026 at 12:07 am IST.

What is the minimum amount required to buy Lyra Therapeutics Inc Stock (LYRA) from India?

Indian investors can start investing in Lyra Therapeutics Inc (LYRA) shares with as little as ₹92.68 or $1 (as of April 4, 2026 at 2:33 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹926.80 in Lyra Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on April 4, 2026 at 2:33 am IST). Based on Lyra Therapeutics Inc share’s latest price of $0.49 as on April 3, 2026 at 12:07 am IST, you will get 20.4082 shares of Lyra Therapeutics Inc. Learn more about fractional shares .